144 related articles for article (PubMed ID: 38313575)
21. Adolescent Facial Acne Vulgaris and Body Mass Index: Any Relationship?
Anaba LE; Ogunbiyi OA; George OA
West Afr J Med; 2019; 36(2):129-132. PubMed ID: 31385598
[TBL] [Abstract][Full Text] [Related]
22. Epidemiology of Acne Vulgaris in 18-Year-Old Male Army Conscripts in a South Brazilian City.
Pereira Duquia R; da Silva Dos Santos I; de Almeida H; Martins Souza PR; de Avelar Breunig J; Zouboulis CC
Dermatology; 2017; 233(2-3):145-154. PubMed ID: 28609760
[TBL] [Abstract][Full Text] [Related]
23. The Psychosocial Impact of Acne Vulgaris.
Hazarika N; Archana M
Indian J Dermatol; 2016; 61(5):515-20. PubMed ID: 27688440
[TBL] [Abstract][Full Text] [Related]
24. Large-scale international study enhances understanding of an emerging acne population: adult females.
Dréno B; Thiboutot D; Layton AM; Berson D; Perez M; Kang S;
J Eur Acad Dermatol Venereol; 2015 Jun; 29(6):1096-106. PubMed ID: 25296739
[TBL] [Abstract][Full Text] [Related]
25. Tazarotene 0.045% Lotion for the Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris in Adult Males.
Cook-Bolden FE; Gold MH; Guenin E
J Drugs Dermatol; 2020 Jan; 19(1):78-85. PubMed ID: 32023013
[TBL] [Abstract][Full Text] [Related]
26. The role of cosmetics in postadolescent acne.
Epinette WW; Greist MC; Ozols II
Cutis; 1982 May; 29(5):500-4, 514. PubMed ID: 6212201
[TBL] [Abstract][Full Text] [Related]
27. Tretinoin gel microspheres 0.04% versus 0.1% in adolescents and adults with mild to moderate acne vulgaris: a 12-week, multicenter, randomized, double-blind, parallel-group, phase IV trial.
Berger R; Rizer R; Barba A; Wilson D; Stewart D; Grossman R; Nighland M; Weiss J
Clin Ther; 2007 Jun; 29(6):1086-97. PubMed ID: 17692723
[TBL] [Abstract][Full Text] [Related]
28. A clinical evaluation of acne scarring and its incidence.
Layton AM; Henderson CA; Cunliffe WJ
Clin Exp Dermatol; 1994 Jul; 19(4):303-8. PubMed ID: 7955470
[TBL] [Abstract][Full Text] [Related]
29. Prevalence and risk factors of facial acne vulgaris among Chinese adolescents.
Wu TQ; Mei SQ; Zhang JX; Gong LF; Wu FJ; Wu WH; Li J; Lin M; Diao JX
Int J Adolesc Med Health; 2007; 19(4):407-12. PubMed ID: 18348416
[TBL] [Abstract][Full Text] [Related]
30. Comparative efficacy and tolerability of dapsone 5% gel in adult versus adolescent females with acne vulgaris.
Del Rosso JQ; Kircik L; Gallagher CJ
J Clin Aesthet Dermatol; 2015 Jan; 8(1):31-7. PubMed ID: 25610522
[TBL] [Abstract][Full Text] [Related]
31. Acne among Patients Visiting Outpatient Department of Dermatology Centres.
Dhakal B; Basnet R; Shrestha B; Yadav BK; Khatiwada B; Goit R; Neupane D; Kharal K
JNMA J Nepal Med Assoc; 2023 Oct; 61(266):811-813. PubMed ID: 38289766
[TBL] [Abstract][Full Text] [Related]
32. Insulin Resistance and Metabolic Syndrome in Young Men With Acne.
Nagpal M; De D; Handa S; Pal A; Sachdeva N
JAMA Dermatol; 2016 Apr; 152(4):399-404. PubMed ID: 26720707
[TBL] [Abstract][Full Text] [Related]
33. Sensitivity to change of the Dermatology Life Quality Index in adult females with facial acne vulgaris: a validation study.
Richter C; Trojahn C; Hillmann K; Dobos G; Kanti V; Vogt A; Blume-Peytavi U; Kottner J
J Eur Acad Dermatol Venereol; 2017 Jan; 31(1):169-174. PubMed ID: 27393576
[TBL] [Abstract][Full Text] [Related]
34. Prevalence and Risk Factors of Acne Scarring Among Patients Consulting Dermatologists in the USA.
Tan J; Kang S; Leyden J
J Drugs Dermatol; 2017 Feb; 16(2):97-102. PubMed ID: 28300850
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and Safety of Once-Daily Dapsone Gel, 7.5% for Treatment of Adolescents and Adults With Acne Vulgaris: Second of Two Identically Designed, Large, Multicenter, Randomized, Vehicle-Controlled Trials.
Eichenfield LF; Lain T; Frankel EH; Jones TM; Chang-Lin JE; Berk DR; Ruan S; Kaoukhov A
J Drugs Dermatol; 2016 Aug; 15(8):962-9. PubMed ID: 27537997
[TBL] [Abstract][Full Text] [Related]
36. Clinical Comparison of Topical 2.5% Benzoyl Peroxide plus 5% Niacinamide to 2.5% Benzoyl Peroxide Alone in the Treatment of Mild to Moderate Facial Acne Vulgaris.
Kaewsanit T; Chakkavittumrong P; Waranuch N
J Clin Aesthet Dermatol; 2021 Jun; 14(6):35-41. PubMed ID: 34804354
[TBL] [Abstract][Full Text] [Related]
37. A randomized, single-blind comparison of topical clindamycin + benzoyl peroxide and adapalene in the treatment of mild to moderate facial acne vulgaris.
Langner A; Chu A; Goulden V; Ambroziak M
Br J Dermatol; 2008 Jan; 158(1):122-9. PubMed ID: 18047518
[TBL] [Abstract][Full Text] [Related]
38. Papular Acne Scars of the Nose and Chin: An Under-recognised Variant of Acne Scarring.
Ali FR; Kirk M; Madan V
J Cutan Aesthet Surg; 2016; 9(4):241-243. PubMed ID: 28163455
[TBL] [Abstract][Full Text] [Related]
39. Acne vulgaris in Nigerian adolescents--prevalence, severity, beliefs, perceptions, and practices.
Yahya H
Int J Dermatol; 2009 May; 48(5):498-505. PubMed ID: 19416381
[TBL] [Abstract][Full Text] [Related]
40. Novel Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris: Assessment of Efficacy and Safety in Patients Aged 9 Years and Older.
Tyring SK; Kircik LH; Pariser DM; Guenin E; Bhatt V; Pillai R
J Drugs Dermatol; 2018 Oct; 17(10):1084-1091. PubMed ID: 30365589
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
